NorthView Acquisition Corporation

NasdaqCM:NVAC Stock Report

Market Cap: US$68.9m

NorthView Acquisition Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Jack Stover

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure3.6yrs
CEO ownershipn/a
Management average tenureno data
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO

Jack Stover (71 yo)

3.6yrs

Tenure

Mr. Jack E. Stover, CPA, served as Director at PharmaCyte Biotech, Inc. since 2022 until November 01, 2022 and he has been Chief Executive Officer, Co-Founder and Director of NorthView Acquisition Corporat...

Board Members

NamePositionTenureCompensationOwnership
Jack Stover
Co-Founder3.6yrsno datano data
Fred Knechtel
Co-Founder3.6yrsno datano data
Haeyong Chung
Independent Director2.9yrsno datano data
Peter O'Rourke
Independent Chairman2.9yrsno datano data
Ed Johnson
Independent Director2.9yrsno datano data

2.9yrs

Average Tenure

63yo

Average Age

Experienced Board: NVAC's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.